VisionGate, Inc., is a breakthrough liquid-biopsy technology company, leading the battle against lung cancer through early detection technology with a simple, non-intrusive sputum test. The foundation for our diagnostics capability is the proprietary Cell-CT™ 3-Dimensional Cell Imaging and Analysis platform. The Cell-CT platform, using a process called optical computed tomography (CT), produces 3D images of individual cells with the ability to morphologically recognize over 700 structural biomarkers of normal and abnormal cells. The Cell-CT platform can process any liquid biopsy specimen and therefore has potential applicability to detect a wide range of different cancers and cancer biosignatures that could aid in identifying potential treatments using targeted pharmaceutical therapies. Our lead diagnostic product is the LuCED® lung test - a non-invasive sputum-based test that detects abnormal cells which indicate lung cancer and bronchial dysplasia. LuCED lung test utilizes the Cell-CT platform and is in development for the early detection of lung cancer, bronchial dysplasia and the assessment of indeterminate pulmonary nodules (IPN). The LuCED test includes CellGazer™ application, an imaging software tool under development to facilitate cytopathology diagnosis of abnormal cell images detected by the Cell-CT platform. Visit www.visiongate3d.com to learn more.
View Top Employees from VisionGate, Inc.Website | http://www.visiongate3d.com/ |
Revenue | $20 million |
Funding | $57.7 million |
Employees | 24 (18 on RocketReach) |
Founded | 2001 |
Address | 10220 South 51st Street Suite 2, Phoenix, Arizona 85044, US |
Phone | (602) 368-2118 |
Technologies |
JavaScript,
HTML,
PHP
+28 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services, Science and Engineering, Health Care, Life Science |
Web Rank | 5 Million |
SIC | SIC Code 38 Companies, SIC Code 382 Companies |
NAICS | NAICS Code 33 Companies, NAICS Code 334 Companies |
Looking for a particular VisionGate, Inc. employee's phone or email?
The VisionGate, Inc. annual revenue was $20 million in 2024.
Chris Presley is the Director of Clinical Research of VisionGate, Inc..
18 people are employed at VisionGate, Inc..
VisionGate, Inc. is based in Phoenix, Arizona.
The NAICS codes for VisionGate, Inc. are [33, 334].
The SIC codes for VisionGate, Inc. are [38, 382].